4GOLD Executive Committee[DB/OL]. Guidelines: Global Strategy for Diagnosis, Management, and Prevention of COPD,November 2006 [ 2006-11-18 ]. http://www.goldcopd.com/Guidelineitem. asp? 11 =2&12 = 1&intId =989.
5Celli BR, MacNee W, Committee members. Standard for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946.
6Celli BR, Cote CG, Matin JM, et al. The body mass index,airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004,350 : 1005-1012.
7David JP.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease 2006[J].Respir Core,2006,51 (3):277-285.
8Buisine MP,Devisme L,Lopin MC,et al.Development mucin gene expression in the human respiratory tract[J].Am J Respir Cell Mol Biol,1999,20 (2):209-218.
9Bames PJ.Current and future therapies for airway mucus hypersectetion[J].Novartie Found Symp,2002,248:237-249.
10Bames PJ.Novel approaches and targets for treatment of chronic obstructive disease[J].Am Respir Crit Care Med,1999,160 (5):72 -79.
